NewCardio, Inc.
NWCI · OTC
9/30/2011 | 6/30/2011 | 3/31/2011 | 12/31/2010 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -90.3% | 159.9% | -55.6% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | -$0 | $0 |
| % Margin | -177.9% | 64.6% | -58% | 23% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $2 | $2 | $2 |
| Operating Income | -$2 | -$2 | -$2 | -$2 |
| % Margin | -15,764.4% | -1,707.4% | -5,042.4% | -2,360.6% |
| Other Income/Exp. Net | -$1 | $1 | -$0 | -$1 |
| Pre-Tax Income | -$2 | -$1 | -$2 | -$3 |
| Tax Expense | $0 | $0 | $0 | $1 |
| Net Income | -$2 | -$1 | -$2 | -$3 |
| % Margin | -23,059.8% | -920.6% | -6,181.4% | -3,645.9% |
| EPS | -0.07 | -0.029 | -0.08 | -0.11 |
| % Growth | -141.4% | 63.8% | 27.3% | – |
| EPS Diluted | -0.07 | -0.029 | -0.08 | -0.11 |
| Weighted Avg Shares Out | 33 | 32 | 31 | 29 |
| Weighted Avg Shares Out Dil | 33 | 32 | 31 | 29 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$1 | -$2 | -$2 |
| % Margin | -21,643.2% | -793.6% | -5,884.5% | -2,336.8% |